Skip to content
Back to RANI

Rani Therapeutics Holdings, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
3
Purchases
2
Sales
1
Purchase value
$50.03K
Sale value
$301.08

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

MIR a ImranDirector · 10% owner
4
Filed Jul 23, 2026Period of report Jul 21, 20260001031686-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJul 21, 2026
Class A Common StockF136,000$0.69$24.84K2,119,334Direct
Filing footnotes · 3
  1. F1The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.688 to $0.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. F2The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  3. F3The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Talat ImranDirector · Chief Executive Officer
4
Filed Jul 21, 2026Period of report Jul 17, 20260001869579-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJul 17, 2026
Class A Common StockF135,000$0.7198$25.19K469,736Direct
Filing footnotes · 1
  1. F1Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Alireza JavadiChief Technical Officer
4
Filed Jul 21, 2026Period of report Mar 27, 20260002123843-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 27, 2026
Class A Common StockF1F2386$0.78$301.089,689Direct
Filing footnotes · 3
  1. F1This transaction is being reported late due to inadvertent administrative oversight.
  2. F2Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of the restricted stock units.
  3. F3Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.